Guenther Boden1. 1. Division of Endocrinology, Diabetes, Metabolism and the Clinical Research Center, Temple University School of Medicine, Philadelphia, Pennsylvania, USA. bodengh@tuhs.temple.edu
Abstract
PURPOSE OF REVIEW: To describe the role of free fatty acid (FFA) as a cause for insulin resistance in obese people. RECENT FINDINGS: Elevated plasma FFA levels can account for a large part of insulin resistance in obese patients with type 2 diabetes. Insulin resistance is clinically important because it is closely associated with several diseases including type 2 diabetes, hypertension, dyslipidemia and abnormalities in blood coagulation and fibrinolysis. These disorders are all independent risk factors for cardiovascular disease (heart attacks, strokes and peripheral arterial disease). The mechanisms by which FFA can cause insulin resistance, although not completely known, include generation of lipid metabolites (diacylglycerol), proinflammatory cytokines (TNF-α, IL-1β, IL-6, MCP1) and cellular stress including oxidative and endoplasmic reticulum stress. SUMMARY: Increased plasma FFA levels are an important cause of obesity-associated insulin resistance and cardiovascular disease. Therapeutic application of this knowledge is hampered by the lack of readily accessible methods to measure FFA and by the lack of medications to lower plasma FFA levels.
PURPOSE OF REVIEW: To describe the role of free fatty acid (FFA) as a cause for insulin resistance in obesepeople. RECENT FINDINGS: Elevated plasma FFA levels can account for a large part of insulin resistance in obesepatients with type 2 diabetes. Insulin resistance is clinically important because it is closely associated with several diseases including type 2 diabetes, hypertension, dyslipidemia and abnormalities in blood coagulation and fibrinolysis. These disorders are all independent risk factors for cardiovascular disease (heart attacks, strokes and peripheral arterial disease). The mechanisms by which FFA can cause insulin resistance, although not completely known, include generation of lipid metabolites (diacylglycerol), proinflammatory cytokines (TNF-α, IL-1β, IL-6, MCP1) and cellular stress including oxidative and endoplasmic reticulum stress. SUMMARY: Increased plasma FFA levels are an important cause of obesity-associated insulin resistance and cardiovascular disease. Therapeutic application of this knowledge is hampered by the lack of readily accessible methods to measure FFA and by the lack of medications to lower plasma FFA levels.
Authors: H O Steinberg; M Tarshoby; R Monestel; G Hook; J Cronin; A Johnson; B Bayazeed; A D Baron Journal: J Clin Invest Date: 1997-09-01 Impact factor: 14.808
Authors: G Paolisso; A Gambardella; M R Tagliamonte; F Saccomanno; T Salvatore; P Gualdiero; M V D'Onofrio; B V Howard Journal: J Clin Endocrinol Metab Date: 1996-12 Impact factor: 5.958
Authors: A Dresner; D Laurent; M Marcucci; M E Griffin; S Dufour; G W Cline; L A Slezak; D K Andersen; R S Hundal; D L Rothman; K F Petersen; G I Shulman Journal: J Clin Invest Date: 1999-01 Impact factor: 14.808
Authors: Islam N Mohamed; Sherif S Hafez; Arwa Fairaq; Adviye Ergul; John D Imig; Azza B El-Remessy Journal: Diabetologia Date: 2013-11-08 Impact factor: 10.122
Authors: Jun Zeng; Yuwen Zhang; Jiaqing Hao; Yanwen Sun; Shujun Liu; David A Bernlohr; Edward R Sauter; Margot P Cleary; Jill Suttles; Bing Li Journal: J Immunol Date: 2018-04-06 Impact factor: 5.422
Authors: A M Quintela; R Jiménez; L Piqueras; M Gómez-Guzmán; J Haro; M J Zarzuelo; A Cogolludo; M J Sanz; M Toral; M Romero; F Pérez-Vizcaíno; J Duarte Journal: Br J Pharmacol Date: 2014-06 Impact factor: 8.739
Authors: Elizabeth F Lopez; Janusz H Kabarowski; Kevin A Ingle; Vasundhara Kain; Stephen Barnes; David K Crossman; Merry L Lindsey; Ganesh V Halade Journal: Am J Physiol Heart Circ Physiol Date: 2014-12-05 Impact factor: 4.733